Architect Ca 15-3 Assay
FDA 510(k) K042732 · Fujirebio Diagnostics,Inc.
510(k) numberK042732
Submission
- Device name
- Architect Ca 15-3 Assay
- Applicant
- Fujirebio Diagnostics,Inc.
Malvern, PA, US - Received
- October 1, 2004
- Decision date
- December 22, 2004
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- MOI – System, Test, Immunological, Antigen, Tumor
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.6010
- Specialty
- Immunology
Other 510(k)s with product code MOI
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K240403 | Access BR MonitorMOI · Traditional | Beckman Coulter, Inc. | 05/09/2024SE |
| K233946 | Immulite® 2000 Br-MaMOI · Traditional | Siemens Healthcare Diagnostics Products, Ltd. | 03/13/2024SE |
| K192524 | Lumipulse G CA15-3MOI · Traditional | Fujirebio Diagnostics,Inc. | 09/04/2020SE |
| K193489 | ADVIA Centaur BRMOI · Traditional | Siemens Healthcare Diagnostics, Inc. | 02/13/2020SE |
| K192777 | ADVIA Centaur CA 15-3 assayMOI · Traditional | Siemens Healthcare Diagnostics, Inc. | 11/22/2019SE |
| K181492 | Elecsys CA 15-3 IIMOI · Traditional | Roche Diagnostics | 06/22/2018SE |
| K171605 | Elecsys CA 15-3 IIMOI · Traditional | Roche Diagnostics | 02/20/2018SE |
| K100344 | Dimension Vista Loci Ca 15-3 Flex Reagent Cartridge, Dimension Vista Loci 7 Calibrator…MOI · Traditional | Siemens Healthcare Diagnostics | 04/18/2011SE |
| K072612 | Access Immunoassay Systems BR Monitor, and Calibrators, Model(S) 387620,AND 387647MOI · Special | Beckman Coulter, Inc. | 10/26/2007SE |
| K033036 | BR Monitor and BR Monitor Calibrators on the Access Immunoassay Systems, Model 387620…MOI · Traditional | Beckman Coulter, Inc. | 02/03/2004SE |
More from Beckman Coulter, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K250925 | ADVIA Centaur Cytokeratin Fragment 21-1OVK · Traditional | 12/16/2025SE |
| K242706 | Lumipulse G pTau217/ß-Amyloid 1-42 Plasma RatioSET · Traditional | 05/16/2025SE |
| K192524 | Lumipulse G CA15-3MOI · Traditional | 09/04/2020SE |
| K192380 | ST Aia-Pack BNPNBC · Traditional | 08/24/2020SE |
| K200997 | Lumipulse G CA19-9-NNIG · Special | 05/14/2020SE |
| K190702 | Lumipulse G whole PTHCEW · Traditional | 08/30/2019SE |
| K172713 | Lumipulse G BRAHMS PCT Immunoreaction Cartridges, Lumipulse G BRAHMS PCT…PRI · Traditional | 12/10/2017SE |
| K171103 | Lumipulse G TSH-III Immunoreaction CartridgesJLW · Traditional | 07/28/2017SE |
| K163546 | Lumipulse G Progesterone-N CalibratorsJIT · Abbreviated | 01/13/2017SE |
| K163534 | Lumipulse G FSH-N CalibratorsJIT · Abbreviated | 01/13/2017SE |
Questions and answers
When was Architect Ca 15-3 Assay cleared by the FDA?
Architect Ca 15-3 Assay (K042732) received a 510(k) decision of Substantially Equivalent on December 22, 2004, 82 days after the submission was received.
What is the product code of K042732?
The FDA product code is MOI – System, Test, Immunological, Antigen, Tumor, a Class II (moderate risk) device regulated under 21 CFR 866.6010.